Business
Eli Lilly’s Weight Loss Drug Shows Promising Results
Eli Lilly's next-generation weight loss drug, retatrutide, showed significant results in a trial, leading to bariatric-surgery levels of weight loss. However, the drug also caused side effects that led some patients to drop out.
Coverage timeline — 2 articles
STAT News
A next-gen Eli Lilly obesity drug led to bariatric-surgery levels of weight loss in a study, but also saw patients dropping out because of side effects.
2026-05-21 10:45 UTC
CNBC
The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.
2026-05-21 10:45 UTC